The metabolic syndrome - Pathogenesis, clinical features and management

Date
2002
Authors
Lombard L.
Augustyn M.N.
Ascott-Evans B.H.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The metabolic syndrome is a highly prevalent clinical entity, which is often overlooked and may have far-reaching health implications for the patient. Up to 80% of patients with the metabolic syndrome die as a result of cardiovascular complications. Insulin resistance is the central component of this complex syndrome and should be appropriately addressed to ensure the best possible outcome for our patients. Recent advances in the pathogenesis and management of this syndrome is discussed in this article.
Description
Keywords
antilipemic agent, beta adrenergic receptor blocking agent, calcium channel blocking agent, dipeptidyl carboxypeptidase inhibitor, diuretic agent, fibric acid derivative, fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor, metformin, nicotinic acid, omega 3 fatty acid, pioglitazone, rosiglitazone, cardiovascular disease, clinical feature, diabetes mellitus, dyslipidemia, human, hyperinsulinemia, hypertension, hyperuricemia, insulin resistance, lifestyle, metabolic disorder, obesity, pathogenesis, review, risk factor, Humans, Metabolic Syndrome X
Citation
Cardiovascular Journal of South Africa
13
4